321 related articles for article (PubMed ID: 35453355)
1. Is Nucleoredoxin a Master Regulator of Cellular Redox Homeostasis? Its Implication in Different Pathologies.
Idelfonso-García OG; Alarcón-Sánchez BR; Vásquez-Garzón VR; Baltiérrez-Hoyos R; Villa-Treviño S; Muriel P; Serrano H; Pérez-Carreón JI; Arellanes-Robledo J
Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453355
[TBL] [Abstract][Full Text] [Related]
2. Flightless-I is a potential biomarker for the early detection of alcoholic liver disease.
Arellanes-Robledo J; Ibrahim J; Reyes-Gordillo K; Shah R; Leckey L; Lakshman MR
Biochem Pharmacol; 2021 Jan; 183():114323. PubMed ID: 33166508
[TBL] [Abstract][Full Text] [Related]
3. Ethanol targets nucleoredoxin/dishevelled interactions and stimulates phosphatidylinositol 4-phosphate production in vivo and in vitro.
Arellanes-Robledo J; Reyes-Gordillo K; Ibrahim J; Leckey L; Shah R; Lakshman MR
Biochem Pharmacol; 2018 Oct; 156():135-146. PubMed ID: 30125555
[TBL] [Abstract][Full Text] [Related]
4. Reduced exploratory behavior in neuronal nucleoredoxin knockout mice.
Tran BN; Valek L; Wilken-Schmitz A; Fuhrmann DC; Namgaladze D; Wittig I; Tegeder I
Redox Biol; 2021 Sep; 45():102054. PubMed ID: 34198070
[TBL] [Abstract][Full Text] [Related]
5. Nucleoredoxin interaction with flightless-I/actin complex is differentially altered in alcoholic liver disease.
Alarcón-Sánchez BR; Guerrero-Escalera D; Rosas-Madrigal S; Ivette Aparicio-Bautista D; Reyes-Gordillo K; Lakshman MR; Ortiz-Fernández A; Quezada H; Medina-Contreras Ó; Villa-Treviño S; Isael Pérez-Carreón J; Arellanes-Robledo J
Basic Clin Pharmacol Toxicol; 2020 Nov; 127(5):389-404. PubMed ID: 32524749
[TBL] [Abstract][Full Text] [Related]
6. Fibrogenic actions of acetaldehyde are β-catenin dependent but Wingless independent: a critical role of nucleoredoxin and reactive oxygen species in human hepatic stellate cells.
Arellanes-Robledo J; Reyes-Gordillo K; Shah R; Domínguez-Rosales JA; Hernández-Nazara ZH; Ramirez F; Rojkind M; Lakshman MR
Free Radic Biol Med; 2013 Dec; 65():1487-1496. PubMed ID: 23880292
[TBL] [Abstract][Full Text] [Related]
7. Nucleoredoxin regulates glucose metabolism via phosphofructokinase 1.
Funato Y; Hayashi T; Irino Y; Takenawa T; Miki H
Biochem Biophys Res Commun; 2013 Nov; 440(4):737-42. PubMed ID: 24120946
[TBL] [Abstract][Full Text] [Related]
8. Cold avoidance and heat pain hypersensitivity in neuronal nucleoredoxin knockout mice.
Valek L; Tran BN; Tegeder I
Free Radic Biol Med; 2022 Nov; 192():84-97. PubMed ID: 36126861
[TBL] [Abstract][Full Text] [Related]
9. Nucleoredoxin Knockdown in SH-SY5Y Cells Promotes Cell Renewal.
Valek L; Tegeder I
Antioxidants (Basel); 2021 Mar; 10(3):. PubMed ID: 33805811
[TBL] [Abstract][Full Text] [Related]
10. Ascorbic acid alters cell fate commitment of human neural progenitors in a WNT/β-catenin/ROS signaling dependent manner.
Rharass T; Lantow M; Gbankoto A; Weiss DG; Panáková D; Lucas S
J Biomed Sci; 2017 Oct; 24(1):78. PubMed ID: 29037191
[TBL] [Abstract][Full Text] [Related]
11. Redox sensitivity of the MyD88 immune signaling adapter.
Stottmeier B; Dick TP
Free Radic Biol Med; 2016 Dec; 101():93-101. PubMed ID: 27720842
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
13. NXN Gene Epigenetic Changes in an Adult Neurogenesis Model of Alzheimer's Disease.
Blanco-Luquin I; Acha B; Urdánoz-Casado A; Gómez-Orte E; Roldan M; Pérez-Rodríguez DR; Cabello J; Mendioroz M
Cells; 2022 Mar; 11(7):. PubMed ID: 35406633
[TBL] [Abstract][Full Text] [Related]
14. Nucleoredoxin negatively regulates Toll-like receptor 4 signaling via recruitment of flightless-I to myeloid differentiation primary response gene (88).
Hayashi T; Funato Y; Terabayashi T; Morinaka A; Sakamoto R; Ichise H; Fukuda H; Yoshida N; Miki H
J Biol Chem; 2010 Jun; 285(24):18586-93. PubMed ID: 20400501
[TBL] [Abstract][Full Text] [Related]
15. STRIPAK complexes: structure, biological function, and involvement in human diseases.
Hwang J; Pallas DC
Int J Biochem Cell Biol; 2014 Feb; 47():118-48. PubMed ID: 24333164
[TBL] [Abstract][Full Text] [Related]
16. TXNIP/TBP-2: A Master Regulator for Glucose Homeostasis.
Yoshihara E
Antioxidants (Basel); 2020 Aug; 9(8):. PubMed ID: 32824669
[TBL] [Abstract][Full Text] [Related]
17. Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases.
Yoshihara E; Masaki S; Matsuo Y; Chen Z; Tian H; Yodoi J
Front Immunol; 2014 Jan; 4():514. PubMed ID: 24409188
[TBL] [Abstract][Full Text] [Related]
18. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.
Selinger M; Věchtová P; Tykalová H; Ošlejšková P; Rumlová M; Štěrba J; Grubhoffer L
Comput Struct Biotechnol J; 2022; 20():2759-2777. PubMed ID: 35685361
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.
Lee S; Kim SM; Lee RT
Antioxid Redox Signal; 2013 Apr; 18(10):1165-207. PubMed ID: 22607099
[TBL] [Abstract][Full Text] [Related]
20. Flightless I homolog negatively regulates ChREBP activity in cancer cells.
Wu L; Chen H; Zhu Y; Meng J; Li Y; Li M; Yang D; Zhang P; Feng M; Tong X
Int J Biochem Cell Biol; 2013 Nov; 45(11):2688-97. PubMed ID: 24055811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
